{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:26:15Z","timestamp":1791872775924,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.diagmicrobio.2022.115717","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T21:54:58Z","timestamp":1651182898000},"page":"115717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Increased rates of extended-spectrum beta-lactamase isolates in patients hospitalized with culture-positive urinary Enterobacterales in the United States: 2011 \u2013 2020"],"prefix":"10.1016","volume":"103","author":[{"given":"Steven I.","family":"Aronin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalvin C.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet A.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0001","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.chest.2019.04.013","article-title":"Infectious disease hospitalizations: United States, 2001 to 2014","volume":"156","author":"Kennedy","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0002","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.2018.12163","article-title":"Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance. A randomized clinical trial","volume":"320","author":"Harris","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0003","doi-asserted-by":"crossref","first-page":"ofz446","DOI":"10.1093\/ofid\/ofz446","article-title":"Longitudinal, nationwide, cohort study to assess incidence, outcomes, and costs associated with complicated urinary tract infection","volume":"6","author":"Carreno","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0004","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.annemergmed.2020.08.022","article-title":"Emergence of extended-spectrum beta-lactamase urinary tract infections among hospitalized emergency department patients in the United States","volume":"77","author":"Talan","year":"2021","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0005","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41585-020-0362-4","article-title":"Epidemiology, definition and treatment of complicated urinary tract infections","volume":"17","author":"Wagenlehner","year":"2020","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0006","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1186\/s12879-019-4387-3","article-title":"Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013-2017","volume":"19","author":"Gupta","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0007","doi-asserted-by":"crossref","first-page":"ofw281","DOI":"10.1093\/ofid\/ofw281","article-title":"The increase in hospitalizations for urinary tract infections and the associated costs in the United States, 1998-2011","volume":"4","author":"Simmering","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0008","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1093\/cid\/ciab560","article-title":"Antimicrobial resistance trends in urine Escherichia coli isolates from adult and adolescent females in the United States from 2011-2019: rising ESBL strains and impact on patient management","volume":"73","author":"Kaye","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0009","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12879-022-07167-y","article-title":"A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011 \u20132019","volume":"22","author":"Dunne","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0010","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1086\/671740","article-title":"Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009","volume":"34","author":"Zilberberg","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0011","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.diagmicrobio.2016.04.022","article-title":"Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010-2014","volume":"85","author":"Lob","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0012","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1309\/502AUPR8VE67MBDE","article-title":"A laboratory-based, hospital-wide, electronic marker for nosocomial infection: the future of infection control surveillance?","volume":"125","author":"Brossette","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0013","doi-asserted-by":"crossref","first-page":"ofy241","DOI":"10.1093\/ofid\/ofy241","article-title":"Carbapenem-nonsusceptible Gram-negative pathogens in ICU and non-ICU settings in US hospitals in 2017: a multicenter study","volume":"5","author":"McCann","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0014","doi-asserted-by":"crossref","first-page":"ofab063","DOI":"10.1093\/ofid\/ofab063","article-title":"A multicenter evaluation of the US prevalence and regional variation in macrolide-resistant S. pneumoniae in ambulatory and hospitalized adult patients in the US","volume":"8","author":"Gupta","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0015","unstructured":"Centers for Medicare & Medicaid Services. Providers of services file\u2014hospital & non-hospital facilities. April 14, 2022. Available at: https:\/\/data.cms.gov\/provider-characteristics\/hospitals-and-other-facilities\/provider-of-services-file-hospital-non-hospital-facilities. Accessed April 15, 2022."},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0016","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijantimicag.2019.04.012","article-title":"In vitro susceptibility of urinary isolates of Escherichia coli to first- and second-line empirically prescribed oral antimicrobial agents: CANWARD surveillance study results for Canadian outpatients from 2007 to 2016","volume":"54","author":"Karlowsky","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2022.115717_bib0017","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/ofid\/ofy347","article-title":"Variations in the occurrence of resistance phenotypes and carbapenemase genes among Enterobacteriaceae isolates in 20 years of the SENTRY antimicrobial surveillance program","volume":"6","author":"Castanheira","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0018","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1017\/ice.2015.239","article-title":"Increasing incidence of extended-spectrum \u03b2-lactamase-producing Escherichia coli in community hospitals throughout the southeastern United States","volume":"37","author":"Thaden","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0019","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.annemergmed.2021.01.003","article-title":"Third-generation cephalosporin resistance and associated discordant antibiotic treatment in emergency department febrile urinary tract infections","volume":"78","author":"Mark","year":"2021","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220265","article-title":"The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017","volume":"14","author":"Critchley","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0021","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.diagmicrobio.2019.02.007","article-title":"Association of systemic antimicrobials with the expression of beta-lactamases in bacteria cultured from urological patients","volume":"94","author":"Forster","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0022","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1186\/s12879-019-4363-y","article-title":"Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections","volume":"19","author":"Lodise","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0023","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.annemergmed.2018.05.006","article-title":"Emergency department urinary tract infections caused by extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: many patients have no identifiable risk factor and discordant empiric therapy is common","volume":"72","author":"Frazee","year":"2018","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0024","unstructured":"Infectious Diseases Society of America. Medicare, Joint Commission update antimicrobial stewardship requirements. February 5, 2020. Available at:https:\/\/www.idsociety.org\/idsa-newsletter\/february-5-2020\/medicare-joint-commission-update-antimicrobial-stewardship-requirements\/. Accessed September 1, 2021."},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0025","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00675-18","article-title":"Human bacterial repertoire of the urinary tract: a potential paradigm shift","volume":"57","author":"Morand","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0026","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1017\/ice.2018.153","article-title":"Hospital microbiology laboratory practices for Enterobacteriaceae: Centers for Disease Control and Prevention National Healthcare Safety Network (NHSN) annual survey, 2015 and 2016","volume":"39","author":"Shugart","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0027","doi-asserted-by":"crossref","first-page":"ofac007","DOI":"10.1093\/ofid\/ofac007","article-title":"Raising the bar: improving antimicrobial resistance detection by clinical laboratories by ensuring use of current breakpoints","volume":"9","author":"Simner","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0028","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1128\/JCM.03613-13","article-title":"Incidence of extended-spectrum-\u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates that test susceptible to cephalosporins and aztreonam by the revised CLSI breakpoints","volume":"52","author":"McWilliams","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0029","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/JCM.02424-15","article-title":"Impact of CLSI breakpoint changes on microbiology laboratories and antimicrobial stewardship programs","volume":"54","author":"Heil","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2022.115717_bib0030","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.2147\/IDR.S329477","article-title":"Appropriateness of empirical fluoroquinolones therapy in patients infected with Escherichia coli, Klebsiella pneumoniae, or Pseudomonas aeruginosa: the importance of the CLSI breakpoints revision","volume":"14","author":"Wang","year":"2021","journal-title":"Infect Drug Resist"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889322000839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889322000839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:57:40Z","timestamp":1760003860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889322000839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0732889322000839"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2022.115717","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased rates of extended-spectrum beta-lactamase isolates in patients hospitalized with culture-positive urinary Enterobacterales in the United States: 2011 \u2013 2020","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2022.115717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115717"}}